These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor. Cui Q; Du R; Anantpadma M; Schafer A; Hou L; Tian J; Davey RA; Cheng H; Rong L Viruses; 2018 Mar; 10(4):. PubMed ID: 29584652 [TBL] [Abstract][Full Text] [Related]
24. T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques. Espy N; Nagle E; Pfeffer B; Garcia K; Chitty AJ; Wiley M; Sanchez-Lockhart M; Bavari S; Warren T; Palacios G Antiviral Res; 2019 Oct; 170():104529. PubMed ID: 31195019 [TBL] [Abstract][Full Text] [Related]
25. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease. Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648 [TBL] [Abstract][Full Text] [Related]
26. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle. Martin B; Canard B; Decroly E Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094 [TBL] [Abstract][Full Text] [Related]
27. The discovery and development of novel treatment strategies for filoviruses. Bradfute SB Expert Opin Drug Discov; 2022 Feb; 17(2):139-149. PubMed ID: 34962451 [TBL] [Abstract][Full Text] [Related]
28. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Feldmann H; Volchkov VE; Volchkova VA; Klenk HD Arch Virol Suppl; 1999; 15():159-69. PubMed ID: 10470276 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin. Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546 [TBL] [Abstract][Full Text] [Related]
30. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species. Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372 [TBL] [Abstract][Full Text] [Related]
31. Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors. Anantpadma M; Kouznetsova J; Wang H; Huang R; Kolokoltsov A; Guha R; Lindstrom AR; Shtanko O; Simeonov A; Maloney DJ; Maury W; LaCount DJ; Jadhav A; Davey RA Antimicrob Agents Chemother; 2016 Aug; 60(8):4471-81. PubMed ID: 27161622 [TBL] [Abstract][Full Text] [Related]
33. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection. Geisbert TW; Strong JE; Feldmann H J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223 [TBL] [Abstract][Full Text] [Related]
34. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection. Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918 [TBL] [Abstract][Full Text] [Related]
35. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses. Chang J; Warren TK; Zhao X; Gill T; Guo F; Wang L; Comunale MA; Du Y; Alonzi DS; Yu W; Ye H; Liu F; Guo JT; Mehta A; Cuconati A; Butters TD; Bavari S; Xu X; Block TM Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725 [TBL] [Abstract][Full Text] [Related]
36. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates. Suschak JJ; Schmaljohn CS Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088 [TBL] [Abstract][Full Text] [Related]
37. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses. Curtis N Adv Exp Med Biol; 2006; 582():35-44. PubMed ID: 16802617 [No Abstract] [Full Text] [Related]
38. Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies. Heald AE; Iversen PL; Saoud JB; Sazani P; Charleston JS; Axtelle T; Wong M; Smith WB; Vutikullird A; Kaye E Antimicrob Agents Chemother; 2014 Nov; 58(11):6639-47. PubMed ID: 25155593 [TBL] [Abstract][Full Text] [Related]
39. In silico exploration of deep-sea fungal metabolites as inhibitor of Ebola and Marburg VP35 and VP40. Alanzi AR; Alajmi MF; Al-Dosari MS; Parvez MK; Alqahtani MJ PLoS One; 2024; 19(7):e0307579. PubMed ID: 39052567 [TBL] [Abstract][Full Text] [Related]
40. Small molecule inhibitors of ebola virus infection. Picazo E; Giordanetto F Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]